Commodore Capital »

Mind Medicine Mindmed shares owned by Commodore Capital

Quarter-by-quarter ownership of Mind Medicine Mindmed (MNMD) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Mind Medicine Mindmed

Tip: Access up to 7 years of quarterly data

All positions including Mind Medicine Mindmed held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mind Medicine Mindmed by Commodore Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $55M 5.8M 9.40

More positions owned by Commodore Capital

Merus N V (MRUS)
Vera Therapeutics Cl A (VERA)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Spyre Therapeutics Com New (SYRE)
Enliven Therapeutics (ELVN)
Vaxcyte (PCVX)
Mind Medicine Mindmed Com New (MNMD)
Alpine Immune Sciences (ALPN)
Arvinas Ord (ARVN)
Rhythm Pharmaceuticals (RYTM)
Cogent Biosciences (COGT)
Pharvaris N V (PHVS)
Celldex Therapeutics Com New (CLDX)
Nkarta (NKTX)

View all positions for Commodore Capital

Top funds holding Mind Medicine Mindmed

Deep Track Capital
Commodore Capital
Driehaus Capital Management
Octagon Capital Advisors
Dr. Jeffrey R. Jay, M.D.
Marshall Wace
Susquehanna International
Blackstone Group
Ally Bridge Group
Woodline Partners
Alyeska Investment Group
Henderson Group
AWM Investment Company
BlackRock
Soleus Capital Management

View all funds holding Mind Medicine Mindmed